Stur E

No ORCID on file · 1 paper in corpus · active 2020
2020
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-19-1026

Abnormal activity of human prolactin (PRL) and its membrane-associated receptor (PRLR) contributes to the progression of uterine carcinoma. However, the underlying mechanisms are not well understood, and current means of targeting the PRL/P…